Clinical study of turmeric (Curcuma longa L.) and Garlic (Allium sativum L.) extracts as antihyperglycemic and antihyperlipidemic agent in type-2 diabetes-dyslipidemia patients

International Journal of Pharmacology

Volumn 6, Issue 4, 2010, Pages 438-445

  Sukandar, E Y ^a   Permana, H ^b   Adnyana, I K ^a   Sigit, J I ^a   Ilyas, R A ^c   Hasimun, P ^a   Mardiyah, D ^a  

^a BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

^b PADJADJARAN UNIVERSITY   (Indonesia)

^c Innogene Kalbiotech Pte Ltd   (Indonesia)

Author keywords

Antihyperglycemic; Antihyperlipidemic; Body mass index; Efficacy; Garlic; Turmeric

Indexed keywords

ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; CURCUMA LONGA EXTRACT PLUS GARLIC EXTRACT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PLACEBO; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSLIPIDEMIA; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; LIPID METABOLISM; LIVER DISEASE; MALE; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL;

EID: 77955591473     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2010.456.463     Document Type: Article

References (40)

1. Afkhami-Ardekani, M., A.R. Kamali-Ardekani and A. Shojaoddiny-Ardekani, 2006. Effects of garlic on serum lipids and blood glucose of type 2 diabetic patients. Int. J. Diab. Dev. Countries, 26: 86-88.
2. Arafa, H.M., 2005. Curcumin attenuates diet induced hypercholesterolemia in rats. Med. Sci. Monit., 11: 228-234.
3. Ashraf, M.Z., M.E. Hussain and M. Fahim, 2005. Antiatherosclerotic effects of dietary supplementations of garlic and turmeric: Restoration of endothelial function in rats. Life Sci., 77: 837-857.
4. Ashraf, R., K. Aamir, A.R. Shaikh and T. Ahmed, 2005. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J. Ayub. Med. Coll. Abbottabad, 17: 60-64.
5. Babu, P.S. and K. Srinivasan, 1997. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol. Cell. Biochem., 166: 169-175.
6. Banerjee, S.K. and S.K. Maulik, 2002. Effect of garlic on cardiovascular disorders: A review. Nutr. J., 1: 1-14.
7. Bundy, R., A.F. Walker, R.W. Middleton and J. Booth, 2004. Turmeric extract may improve irritable bowel syndrome symptomology in otherwise healthy adults: A pilot study. J. Alter. Complement. Med., 10: 1015-1018.
8. Chang, M.L.W. and M.A. Johnson, 1980. Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J. Nutr., 110: 931-936.
9. Coon, J.T. and E. Ernst, 2002. Systematic review: Herbal medicinal products for non-ulcer dyspepsia. Aliment. Pharmacol. Ther., 16: 1689-1699.
10. Duda, G., J. Suliburska and D. Pupek-Musialik, 2008. Effects of short-term garlic supplementation on lipid metabolism and antioxidant status in hypertensive adults. Pharmacol. Reports, 60: 163-170.
11. Eckel, R.H., 2008. Diabetic dyslipidemia and cardiovascular risk. Curr. Diab. Rep., 8: 421-423.
12. Eidi, A., M. Eidi and E. Esmaeili, 2006. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-induced diabetic rats. Phytomedicine, 13: 624-629.
13. Eyong, E.U., G.E. Egbung, I.J. Atangwho and P.E. Ebong, 2008. The antidiabetic efficacy of combined extracts from two continental plants: Azadirachta indica (A. Juss) (Neem) and Vernonia amygdalina (Del.) (African Bitter Leaf). Am. J. Biochem. Biotehcnol., 4: 239-244.
14. Fujiwara, H., M. Hosokawa, X. Zhou, S. Fujimotoand K. Fukuda et al., 2008. Curcumin inhibits glucose production in isolated mice hepatocytes. Diabetes Res. Clin. Pract., 80: 185-190.
15. Hossain, P., B. Kawar and M. El-Nahas, 2007. Obesity and diabetes in the developing world-A growing challenge. New Engl. J. Med., 356: 213-215.
16. Hussain, H.E.M.A., 2002. Hypoglycemic, hypolipidemic and antioxidant properties of combination of curcumin from curcuma longa Linn, and partially purified product from abroma augusta, Linn, in streptozotocin induced diabetes. Indian J. Clin. Biochem., 17: 33-43.
17. Iribarren, C., A.J. Karter, A.S. Go, A. Ferrara, J.Y.Liu, S. Sidney and J. V. Selby, 2001. Glycemic control and heart failure among adult patients with diabetes. Circulation, 103: 2668-2673.
18. Itokawa, H., Q. Shi, T. Akiyama, S.L. Morris-Natschke and K.H. Lee, 2008. Recent advances in the investigation of curcuminoids. Chin. Med., 3: 11-11.
19. Jain, R.C. and C.R. Vyas, 1975. Garlic in alloxan-induced diabetic rabbits. Am. J. Clin. Nutr., 28: 684-685.
20. Jain, S.K., J. Rains and K. Jones, 2006. Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels. Free. Radic. Biol. Med., 41: 92-96.
21. Jang, E.M., M.S. Choi, U.J. Jung, M.J. Kim and H.J. Kim etal., 2008. Beneficial effects of curcumin on hyperlipidemia and insulin resistance in high-fat-fed hamster. Metab. Clin. Exp., 57: 1576-1583.
22. Kuroda, M., Y. Mimaki, T. Nishiyama, T. Mae and H. Kishida et al., 2005. Hypoglycemic effects of turmeric (Curcuma longa L. Rhizomes) on genetically diabetic KK-Ay mice. Biol. Phann. Bull., 28: 937-939.
23. Lau, B.H., 2001. Suppression of LDL oxidation by garlic. J. Nutr., 131: 985S-988S.
24. Lau, B.H.S., F. Lam and R. Wang-Cheng, 1987. Effect of an odor-modified garlic preparation on blood lipids. Nutr. Res., 7: 139-149.
25. Lim, H.W., H.Y. Lim and K.P. Wong, 2009. Uncoupling of oxidative phosphorylation by curcumin: Implication of its cellular mechanism of action. Biochem. Biophys. Res. Com., 389: 187-192.
26. Maheshwari, R.K., A.K. Singh, J. Gaddipati and R.C. Srimal, 2006. Multiple biological activities of curcumin: A short review. Life Sci., 78: 2081-2087.
27. Mooradian, A.D., 2009. Dyslipidemia in type 2 diabetes mellitus. Nat. Clin. Pract. Endocrin. Metab., 5:150-159.
28. Nwozo, S., O. Adaramoye and E. Ajaiyeoba, 2009. Oral administration of extract from Curcuma longa lowers blood glucose and attenuates alloxan-induced hyperlipidemia in diabetic rabbits. Pak. J. Nutr., 8: 625-628.
29. Orekhov, A.N. and J. Grunwald, 1997. Effects of garlic on atherosclerosis. Nutrition, 13: 656-663.
30. Patumraj, S., S. Tewit, S. Amatyakul, A. Jariyapongskul, S. Maneesri, V. Kasantikul and D. Shepro, 2000. Comparative effects of garlic and aspirin on diabetic cardiovascular complications. Drug Deliv., 7: 91-96.
31. Peschel, D., R. Koerting and N. Nass, 2007. Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J. Nutr. Biochem., 18: 113-119.
32. Prasad, R., M.K. Rose, M. Virmani, S.L. Garg and J.P. Puri, 2009. Lipid profile of chicken (Gallus domesticus) in response to dietaiy supplementation of garlic (Allium sativum). Int. J. Poult. Sci., 8: 270-276.
33. Saudek, C.D., W.H. Herman, D.B. Sacks, R.M. Bergenstal, D. Edelman and M.B. Davidson, 2008. A new look at screening and diagnosing diabetes mellitus. J. Clin. Endocrinol. Metab., 93: 2447-2453.
34. Selvin, E., J. Coresh, S.H. Golden, F.L. Brancati, A.R. Folsom and M.W. Steffes, 2005. Glycemic control and coronary heart disease risk in persons with and without diabetes. Arch. Int. Med., 165: 1910-1916.
35. Sukandar, E.Y., I. Fidrianny and A.N. Garmana, 2008. Effect of garlic and turmeric extracts on Swiss-Webster mice fetus. J. Kedokt. Maranatha., 8: 36-44.
36. Superko, H.R. and R.M. Krauss, 2000. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein (a). J. Am. Coll. Cardiol., 35: 321-326.
37. Thomson, M., Z.M. Al-Amin, K.K Al-Qattan, L.H. Shaban and M. Ah, 2007. Anti-diabetic and hypolipidaemic properties of garlic (Allium sativum) in stereptozotocin-induced diabetic rats. Int. J. Diabetes Metabol., 15: 108-115.
38. Tiwari, A.K. and J. Madhusudana-Rao, 2002. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr. Sci., 83: 30-38.
39. Weisberg, S.P., R. Leibel and D.V. Tortonello, 2008. Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology, 149: 3549-3558.
40. Yeh, Y.Y. and L. Liu, 2001. Cholesterol-lowering effect of garlic extracts and organosulfur compounds: Human and animal studies. J. Nutr., 131: 989S-993S.